STIFEL FINANCIAL CORP - REATA PHARMACEUTICALS INC ownership

REATA PHARMACEUTICALS INC's ticker is RETA and the CUSIP is 75615P103. A total of 204 filers reported holding REATA PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 2.50 and the average weighting 1.1%.

Quarter-by-quarter ownership
STIFEL FINANCIAL CORP ownership history of REATA PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2023$1,527,674
+13.1%
14,983
+0.8%
0.00%0.0%
Q1 2023$1,350,975
+230.6%
14,859
+38.1%
0.00%
+100.0%
Q4 2022$408,629
+59.6%
10,756
+5.8%
0.00%
Q3 2022$256,000
-19.2%
10,169
-2.6%
0.00%
Q2 2022$317,000
-8.6%
10,437
-1.4%
0.00%
Q1 2022$347,000
+37.2%
10,584
+10.4%
0.00%
Q4 2021$253,000
-94.3%
9,590
-78.3%
0.00%
-100.0%
Q3 2021$4,455,000
-29.7%
44,284
-1.1%
0.01%
-22.2%
Q2 2021$6,334,000
+51.0%
44,759
+6.4%
0.01%
+28.6%
Q1 2021$4,195,000
-12.8%
42,075
+8.1%
0.01%
-22.2%
Q4 2020$4,812,000
+61.9%
38,923
+27.5%
0.01%
+50.0%
Q3 2020$2,973,000
-47.0%
30,521
-15.1%
0.01%
-53.8%
Q2 2020$5,612,000
+9.3%
35,970
+1.0%
0.01%
-7.1%
Q1 2020$5,134,000
-17.3%
35,624
+16.9%
0.01%
+7.7%
Q4 2019$6,210,000
+149.5%
30,466
-2.0%
0.01%
+116.7%
Q3 2019$2,489,000
-13.5%
31,072
+1.7%
0.01%
-14.3%
Q2 2019$2,879,000
+4.8%
30,553
-4.5%
0.01%
-12.5%
Q1 2019$2,747,000
+70.7%
31,985
+11.7%
0.01%
+60.0%
Q4 2018$1,609,000
-36.9%
28,629
-8.5%
0.01%
-28.6%
Q3 2018$2,550,000
+155.8%
31,278
+8.7%
0.01%
+133.3%
Q2 2018$997,000
+73.4%
28,786
+2.2%
0.00%
+50.0%
Q1 2018$575,000
+151.1%
28,170
+247.7%
0.00%
+100.0%
Q4 2017$229,0008,1010.00%
Other shareholders
REATA PHARMACEUTICALS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Conrad N. Hilton Foundation 63,481$7,847,000100.00%
CPMG Inc 2,896,901$358,115,00055.16%
PARAGON ASSOCIATES & PARAGON ASSOCIATES II JOINT VENTURE 140,000$17,307,00026.62%
Corriente Advisors, LLC 525,000$64,901,00015.45%
DUMAC, INC. 76,050$9,401,0007.33%
MADDEN SECURITIES Corp 35,152$4,345,0002.80%
Biondo Investment Advisors, LLC 113,692$14,055,0002.69%
Duquesne Family Office 749,897$92,702,0002.50%
LBJ Family Wealth Advisors, Ltd. 30,368$3,754,0002.44%
Integral Health Asset Management, LLC 50,000$6,181,0001.84%
View complete list of REATA PHARMACEUTICALS INC shareholders